Found: 17
Select item for more details and to access through your institution.
Slow growing bacteria survive bacteriophage in isolation.
- Published in:
- ISME Communications, 2023, v. 3, n. 1, p. 1, doi. 10.1038/s43705-023-00299-5
- By:
- Publication type:
- Article
Inhaled Liposomal Ciprofloxacin Protects against a Lethal Infection in a Murine Model of Pneumonic Plague.
- Published in:
- Frontiers in Microbiology, 2017, v. 8, p. 1, doi. 10.3389/fmicb.2017.00091
- By:
- Publication type:
- Article
CD4.
- Published in:
- European Journal of Immunology, 2011, v. 41, n. 1, p. 107, doi. 10.1002/eji.201040881
- By:
- Publication type:
- Article
Phage-induced efflux down-regulation boosts antibiotic efficacy.
- Published in:
- PLoS Pathogens, 2024, v. 20, n. 6, p. 1, doi. 10.1371/journal.ppat.1012361
- By:
- Publication type:
- Article
In Vitro Activity of Finafloxacin against Panels of Respiratory Pathogens.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 7, p. 1096, doi. 10.3390/antibiotics12071096
- By:
- Publication type:
- Article
In Vitro Activity of Novel Topoisomerase Inhibitors against Francisella tularensis and Burkholderia pseudomallei.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 6, p. 983, doi. 10.3390/antibiotics12060983
- By:
- Publication type:
- Article
The BALB/c Mouse Model for the Evaluation of Therapies to Treat Infections with Aerosolized Burkholderia pseudomallei.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 3, p. 506, doi. 10.3390/antibiotics12030506
- By:
- Publication type:
- Article
An Investigation into the Re-Emergence of Disease Following Cessation of Antibiotic Treatment in Balb/c Mice Infected with Inhalational Burkholderia pseudomallei.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 10, p. N.PAG, doi. 10.3390/antibiotics11101442
- By:
- Publication type:
- Article
Differences in the gut microbiota between Gurkhas and soldiers of British origin.
- Published in:
- PLoS ONE, 2023, v. 18, n. 12, p. 1, doi. 10.1371/journal.pone.0292645
- By:
- Publication type:
- Article
Investigation of a combination therapy approach for the treatment of melioidosis.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.934312
- By:
- Publication type:
- Article
Finafloxacin, a Novel Fluoroquinolone, Reduces the Clinical Signs of Infection and Pathology in a Mouse Model of Q Fever.
- Published in:
- Frontiers in Microbiology, 2021, v. 12, p. 1, doi. 10.3389/fmicb.2021.760698
- By:
- Publication type:
- Article
Establishing an In Vivo Imaging Capability in High-Containment.
- Published in:
- Applied Biosafety: Journal of the American Biological Safety Association, 2016, v. 21, n. 1, p. 5, doi. 10.1177/1535676016631878
- By:
- Publication type:
- Article
Efficacy of finafloxacin in a murine model of inhalational glanders.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.1057202
- By:
- Publication type:
- Article
Drug screening to identify compounds to act as co-therapies for the treatment of Burkholderia species.
- Published in:
- PLoS ONE, 2021, v. 16, n. 3, p. 1, doi. 10.1371/journal.pone.0248119
- By:
- Publication type:
- Article
The lytic transglycosylase, LtgG, controls cell morphology and virulence in Burkholderia pseudomallei.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-47483-z
- By:
- Publication type:
- Article
Individual bacteria in structured environments rely on phenotypic resistance to phage.
- Published in:
- PLoS Biology, 2021, v. 19, n. 10, p. 1, doi. 10.1371/journal.pbio.3001406
- By:
- Publication type:
- Article
The Fluoroquinolone Finafloxacin Protects BALB/c Mice Against an Intranasal Infection With Francisella tularensis Strain SchuS4.
- Published in:
- Frontiers in Microbiology, 2019, p. N.PAG, doi. 10.3389/fmicb.2019.00904
- By:
- Publication type:
- Article